214 related articles for article (PubMed ID: 21719137)
1. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Nowsheen S; Bonner JA; Yang ES
Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer.
Nowsheen S; Bonner JA; Lobuglio AF; Trummell H; Whitley AC; Dobelbower MC; Yang ES
PLoS One; 2011; 6(8):e24148. PubMed ID: 21912620
[TBL] [Abstract][Full Text] [Related]
3. Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells.
Hsu HW; de Necochea-Campion R; Williams V; Duerksen-Hughes PJ; Simental AA; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jul; 50(7):662-9. PubMed ID: 24735547
[TBL] [Abstract][Full Text] [Related]
4. Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models.
Frederick BA; Gupta R; Atilano-Roque A; Su TT; Raben D
Radiat Res; 2020 Nov; 194(5):519-531. PubMed ID: 32936912
[TBL] [Abstract][Full Text] [Related]
5. DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma.
Weaver AN; Cooper TS; Rodriguez M; Trummell HQ; Bonner JA; Rosenthal EL; Yang ES
Oncotarget; 2015 Sep; 6(29):26995-7007. PubMed ID: 26336991
[TBL] [Abstract][Full Text] [Related]
6. A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia.
Liu SK; Coackley C; Krause M; Jalali F; Chan N; Bristow RG
Radiother Oncol; 2008 Aug; 88(2):258-68. PubMed ID: 18456354
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.
Albert JM; Cao C; Kim KW; Willey CD; Geng L; Xiao D; Wang H; Sandler A; Johnson DH; Colevas AD; Low J; Rothenberg ML; Lu B
Clin Cancer Res; 2007 May; 13(10):3033-42. PubMed ID: 17505006
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors.
Mangoni M; Sottili M; Salvatore G; Meattini I; Desideri I; Greto D; Loi M; Becherini C; Garlatti P; Delli Paoli C; Dominici L; Gerini C; Scoccianti S; Bonomo P; Silvano A; Beltrami G; Campanacci D; Livi L
Radiat Res; 2018 Nov; 190(5):464-472. PubMed ID: 30067444
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models.
Guillot C; Favaudon V; Herceg Z; Sagne C; Sauvaigo S; Merle P; Hall J; Chemin I
BMC Cancer; 2014 Aug; 14():603. PubMed ID: 25139788
[TBL] [Abstract][Full Text] [Related]
10. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
Schlicker A; Peschke P; Bürkle A; Hahn EW; Kim JH
Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
Raju U; Riesterer O; Wang ZQ; Molkentine DP; Molkentine JM; Johnson FM; Glisson B; Milas L; Ang KK
Radiother Oncol; 2012 Nov; 105(2):241-9. PubMed ID: 23010482
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia.
Lee TW; Wong WW; Dickson BD; Lipert B; Cheng GJ; Hunter FW; Hay MP; Wilson WR
Int J Radiat Biol; 2019 Dec; 95(12):1597-1612. PubMed ID: 31490091
[No Abstract] [Full Text] [Related]
13. Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
Zhou ZR; Zhu XD; Zhao W; Qu S; Su F; Huang ST; Ma JL; Li XY
Oncol Rep; 2013 Jun; 29(6):2498-506. PubMed ID: 23563481
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomas.
Yang SX; Kummar S; Steinberg SM; Murgo AJ; Gutierrez M; Rubinstein L; Nguyen D; Kaur G; Chen AP; Giranda VL; Tomaszewski JE; Doroshow JH;
Cancer Biol Ther; 2009 Nov; 8(21):2004-9. PubMed ID: 19823047
[TBL] [Abstract][Full Text] [Related]
15. Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines.
Nasuno T; Mimaki S; Okamoto M; Esumi H; Tsuchihara K
Cancer Sci; 2014 Feb; 105(2):202-10. PubMed ID: 24219164
[TBL] [Abstract][Full Text] [Related]
16. Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells.
Ji J; Kinders RJ; Zhang Y; Rubinstein L; Kummar S; Parchment RE; Tomaszewski JE; Doroshow JH
PLoS One; 2011; 6(10):e26152. PubMed ID: 22028822
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation.
Hirai T; Shirai H; Fujimori H; Okayasu R; Sasai K; Masutani M
Cancer Sci; 2012 Jun; 103(6):1045-50. PubMed ID: 22404155
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.
Bonner JA; Yang ES; Trummell HQ; Nowsheen S; Willey CD; Raisch KP
Radiother Oncol; 2011 Jun; 99(3):339-43. PubMed ID: 21704410
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.
Veuger SJ; Curtin NJ; Richardson CJ; Smith GC; Durkacz BW
Cancer Res; 2003 Sep; 63(18):6008-15. PubMed ID: 14522929
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines.
Güster JD; Weissleder SV; Busch CJ; Kriegs M; Petersen C; Knecht R; Dikomey E; Rieckmann T
Radiother Oncol; 2014 Dec; 113(3):345-51. PubMed ID: 25467050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]